Literature DB >> 20517649

Genetic analysis of BIRC4/XIAP as a putative modifier gene of Wilson disease.

Karl Heinz Weiss1, Heiko Runz, Barbara Noe, Daniel Nils Gotthardt, Uta Merle, Peter Ferenci, Wolfgang Stremmel, Joachim Füllekrug.   

Abstract

Wilson disease (WD) is an autosomal-recessive copper overload disorder caused by mutations in the copper-transporting adenosine triphosphatase (ATPase) ATP7B. It presents with a highly variable clinical phenotype ranging from asymptomatic to fulminant hepatic failure or progressive neurological involvement. No clear genotype-phenotype correlation has been established. Thus, variants in modifier genes could have an impact on WD manifestation and severity. Recently, the antiapoptotic protein baculoviral IAP repeat-containing protein 4 BIRC4/XIAP has been suggested as a regulator of copper-induced cell death. With the aim of investigating a putative role of BIRC4/XIAP as modifier gene in individuals with copper overload, we analyzed a WD patient cohort (n = 98) for sequence variants at the BIRC4/XIAP locus. When compared with clinical data, the previously described coding single nucleotide polymorphisms (SNPs) at the BRIC4/XIAP locus (rs28382721, rs28382722, rs28382723, rs5956583, rs28382740, rs12838858, rs28382741) did not correlate with age of onset or clinical presentation in our collective. However, three previously unreported variants in the BIRC4/XIAP gene were identified (c.1-26 T > G; c.1408A > T; p.T470S; c.1019A > G; p.N340S). The two patients with variants leading to amino acid exchanges in the BIRC4/XIAP protein showed a remarkably early disease onset at the age of 5 years. Furthermore, one of these patients was only heterozygous for disease-causing mutations in the ATP7B gene. In summary, these data emphasize the need to further elucidate a role of BIRC4/XIAP variants as putative pathogenetic factors in copper overload disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20517649     DOI: 10.1007/s10545-010-9123-5

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  46 in total

1.  Accounting for human polymorphisms predicted to affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Genome Res       Date:  2002-03       Impact factor: 9.043

2.  A practice guideline on Wilson disease.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

3.  Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses.

Authors:  A B Shah; I Chernov; H T Zhang; B M Ross; K Das; S Lutsenko; E Parano; L Pavone; O Evgrafov; I A Ivanova-Smolenskaya; G Annerén; K Westermark; F H Urrutia; G K Penchaszadeh; I Sternlieb; I H Scheinberg; T C Gilliam; K Petrukhin
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 4.  Wilson's disease.

Authors:  Aftab Ala; Ann P Walker; Keyoumars Ashkan; James S Dooley; Michael L Schilsky
Journal:  Lancet       Date:  2007-02-03       Impact factor: 79.321

5.  Wilson disease in septuagenarian siblings: Raising the bar for diagnosis.

Authors:  Aftab Ala; Jimo Borjigin; Arnold Rochwarger; Michael Schilsky
Journal:  Hepatology       Date:  2005-03       Impact factor: 17.425

6.  COMMD1 (MURR1) as a candidate in patients with copper storage disease of undefined etiology.

Authors:  V A Coronado; J A Bonneville; H Nazer; E A Roberts; D W Cox
Journal:  Clin Genet       Date:  2005-12       Impact factor: 4.438

7.  Functional consequences of RNA interference targeting COMMD1 in a canine hepatic cell line in relation to copper toxicosis.

Authors:  B Spee; B Arends; A M T C van Wees; P Bode; L C Penning; J Rothuizen
Journal:  Anim Genet       Date:  2007-03-12       Impact factor: 3.169

Review 8.  Cellular copper transport and metabolism.

Authors:  E D Harris
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

9.  Sequence analysis of BIRC4/XIAP in male patients with common variable immunodeficiency.

Authors:  Ulrich Salzer; Tina Hagena; David B Webster; Bodo Grimbacher
Journal:  Int Arch Allergy Immunol       Date:  2008-06-03       Impact factor: 2.749

10.  Differential allelic expression in the human genome: a robust approach to identify genetic and epigenetic cis-acting mechanisms regulating gene expression.

Authors:  David Serre; Scott Gurd; Bing Ge; Robert Sladek; Donna Sinnett; Eef Harmsen; Marina Bibikova; Eugene Chudin; David L Barker; Todd Dickinson; Jian-Bing Fan; Thomas J Hudson
Journal:  PLoS Genet       Date:  2008-02-29       Impact factor: 5.917

View more
  22 in total

Review 1.  Genome-wide association studies and genetic risk assessment of liver diseases.

Authors:  Marcin Krawczyk; Roman Müllenbach; Susanne N Weber; Vincent Zimmer; Frank Lammert
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 2.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

3.  Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease.

Authors:  T Litwin; G Gromadzka; J Samochowiec; A Grzywacz; A Członkowski; A Członkowska
Journal:  JIMD Rep       Date:  2012-07-06

4.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

5.  Molecular genetic diagnosis of Wilson disease by ARMS-PCR in a Pakistani family.

Authors:  Haq Nawaz Khan; Muhammad Wasim; Hina Ayesha; Fazli Rabbi Awan
Journal:  Mol Biol Rep       Date:  2018-11-13       Impact factor: 2.316

6.  Decreased serum antioxidant capacity in patients with Wilson disease is associated with neurological symptoms.

Authors:  Radan Bruha; Libor Vitek; Zdenek Marecek; Lenka Pospisilova; Sona Nevsimalova; Pavel Martasek; Jaromir Petrtyl; Petr Urbanek; Alena Jiraskova; Ivana Malikova; Martin Haluzik; Peter Ferenci
Journal:  J Inherit Metab Dis       Date:  2011-12-03       Impact factor: 4.982

Review 7.  Evolving perspectives in Wilson disease: diagnosis, treatment and monitoring.

Authors:  Karl Heinz Weiss; Wolfgang Stremmel
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 8.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

9.  Wilson's disease: changes in methionine metabolism and inflammation affect global DNA methylation in early liver disease.

Authors:  Valentina Medici; Noreene M Shibata; Kusum K Kharbanda; Janine M LaSalle; Rima Woods; Sarah Liu; Jesse A Engelberg; Sridevi Devaraj; Natalie J Török; Joy X Jiang; Peter J Havel; Bo Lönnerdal; Kyoungmi Kim; Charles H Halsted
Journal:  Hepatology       Date:  2013-01-10       Impact factor: 17.425

10.  Detection and impact of rare regulatory variants in human disease.

Authors:  Xin Li; Stephen B Montgomery
Journal:  Front Genet       Date:  2013-05-31       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.